Despite the promising anti-diabetic effects of myricitrin reported in previous studies, its precise mechanisms in glucose and lipid metabolism, as well as its effect on pancreatic insulin expression, in a well-established type 2 diabetes model like db/db mice, characterized by obesity, hyperinsulinemia, insulin resistance, and MASLD, remain unclear. This evidence concerns the gene INS and Hyperinsulinemia.